PULMONARY FIBROSIS

This adverse event was reported 19202 times

These drugs are most commonly taken by patients reporting PULMONARY FIBROSIS:

# Drug Count
0 METHOTREXATE SODIUM 3998
1 METHOTREXATE 3511
2 PREDNISONE 3480
3 ADALIMUMAB 3047
4 ETANERCEPT 2763
5 RITUXIMAB 2633
6 LEFLUNOMIDE 2396
7 TOCILIZUMAB 2258
8 FOLIC ACID 2236
9 ALENDRONATE SODIUM 2152
See all common drugs associated with PULMONARY FIBROSIS

PULMONARY FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIPROLIDINE HYDROCHLORIDE 112 0.5744
1 TRICLOSAN 137 0.2374
2 CAFFEINE CITRATE 427 0.1829
3 GOLIMUMAB 1741 0.1383
4 ASIAN GINSENG 57 0.1351
5 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 76 0.1155
6 DICLOFENAC POTASSIUM TABLETS 900 0.1038
7 CLEAR MINT, GEL TOOTHPASTE 95 0.0866
8 SODIUM FLUORIDE F18 95 0.0860
9 SODIUM FLUORIDE F-18 95 0.0857
See all drugs enriched for association with PULMONARY FIBROSIS

PULMONARY FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 490 0.7122
1 Endoglycosidase [EPC] 160 0.0863
2 Provitamin D2 Compound [EPC] 1810 0.0608
3 Antihypoglycemic Agent [EPC] 179 0.0417
4 Interleukin-17A Antagonist [EPC] 1460 0.0392
5 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 304 0.0349
6 Sulfonamide Antibacterial [EPC] 123 0.0308
7 Antirheumatic Agent [EPC] 2400 0.0227
8 Aminosalicylate [EPC] 2160 0.0214
9 Interleukin-6 Receptor Antagonist [EPC] 2341 0.0169
See all drug classes enriched for association with PULMONARY FIBROSIS